<DOC>
	<DOCNO>NCT00944385</DOCNO>
	<brief_summary>According TEG ( thromboelastography ) , maximum amplitude increase amount bleed transfusion Cardiac enzyme reduce use ulinastatin .</brief_summary>
	<brief_title>Effects Ulinastatin Myocardial Protection Blood Loss Patients Undergoing Aortic Valve Replacement</brief_title>
	<detailed_description />
	<mesh_term>Urinastatin</mesh_term>
	<criteria>40 % output leave ventricle tricuspid valve failure moderate severe urgent surgery require infectious endocarditis</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2011</verification_date>
</DOC>